Analysis of Placental Tissue in Fabry Disease With and Without Enzyme Replacement Therapy

Placenta

Volumn 31, Issue 4, 2010, Pages 344-346

  Bouwman, M G ^a   Hollak, C E M ^b   van den Bergh Weerman, M A ^c   Wijburg, F A ^a   Linthorst, G E ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Division of Endocrinology and Metabolism   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Fabry disease; Histology; Placenta

Indexed keywords

AGALSIDASE BETA; ALPHA GALACTOSIDASE;

ADULT; ARTICLE; AUDIOGRAPHY; CASE REPORT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; INFORMED CONSENT; MALE; MOTHER; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEINURIA; SMOOTH MUSCLE FIBER; UMBILICAL CORD;

ADULT; ALPHA-GALACTOSIDASE; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; FEMALE; GLYCOSPHINGOLIPIDS; HUMANS; INFANT, NEWBORN; ISOENZYMES; MALE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; UMBILICAL CORD;

EID: 77950370872     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.02.004     Document Type: Article

References (4)

1. Desnick R.J., Ioannou Y.A., and Eng M.E. α-Galactosidase A deficiency: Fabry disease. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 3733-3774
2. Vedder A.C., Strijland A., vd Bergh Weerman M.A., Florquin S., Aerts J.M.F.G., and Hollak C.E.M. Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis 29 (2006) 106-111
3. Elleder M., Poupetova H., and Kozich V. [Fetal pathology in Fabry's disease and mucopolysaccharidosis type 1]. Cesk Patol 34 (1998) 7-12
4. Popli S., Leehey D.J., Molnar Z.V., Nawab Z.M., and Ing T.S. Demonstration of Fabry's disease deposits in placenta. Am J Obstet Gynecol 162 (1990) 464-465